Loading stock data…
$3.23+0.07 (+2.38%)
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Quanterix Corporation in the Healthcare sector is trading at $3.23 with a market capitalization of $125M. Wall Street consensus targets $3.17 (3 analysts), implying a -1.8% move over the next 12 months. The stock is currently near its 52-week low of $2.15, remaining 21.3% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $32.91M↓ | $36.41M↓ | $43.78M↑ | $40.15M↑ | $24.48M |
| Gross Profit | $12.67M↓ | $15.57M↓ | $19.96M↑ | $17.12M↑ | $10.00M |
| Operating Income | -$22.50M↓ | -$21.53M↑ | -$23.87M↑ | -$30.15M↓ | -$29.43M |
| Net Income | -$48.93M↓ | -$17.54M↑ | -$23.12M↑ | -$33.52M↓ | -$30.01M |
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Si...